We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+6.7%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+433.28%
AUM
$164B
AUM Growth
+$34B
Cap. Flow
+$21.1B
Cap. Flow %
12.82%
Top 10 Hldgs %
19.02%
Holding
8,908
New
1,440
Increased
3,569
Reduced
2,696
Closed
989

Sector Composition

Rank Sector Weight
1 Technology 6.08%
2 Financials 6.03%
3 Industrials 5.01%
4 Consumer Discretionary 4.73%
5 Healthcare 4.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SNCR
7176
CALL
DELISTED
Synchronoss Technologies
SNCR
$127K ﹤0.01%
1,578
-2,555
-62% -$247K
AMRN
7177
CALL
Amarin Corp
AMRN
$297M
$126K ﹤0.01%
1,570
-160
-9% -$11K
ODP
7178
CALL
DELISTED
ODP
ODP
$126K ﹤0.01%
3,570
-1,710
-32% -$59.2K
OAKS
7179
DELISTED
Five Oaks Investment Corp.
OAKS
$126K ﹤0.01%
+31,546
New +$132K
ENZY
7180
DELISTED
Enzymotec Ltd
ENZY
$126K ﹤0.01%
+10,623
New +$123K
HIX
7181
Western Asset High Income Fund II
HIX
$350M
$125K ﹤0.01%
+17,866
New +$126K
LAB icon
7182
CALL
Standard BioTools
LAB
$339M
$125K ﹤0.01%
+21,200
New +$116K
NGNE icon
7183
Neurogene
NGNE
$656M
$125K ﹤0.01%
533
-151
-22% -$35.4K
CTLP
7184
DELISTED
Cantaloupe
CTLP
$124K ﹤0.01%
12,680
-4,095
-24% -$31.4K
BCOV
7185
DELISTED
Brightcove, Inc.
BCOV
$124K ﹤0.01%
+17,533
New +$127K
KSM
7186
DELISTED
DWS Strategic Municipal Income Trust
KSM
$124K ﹤0.01%
+10,486
New +$126K
PEI
7187
CALL
DELISTED
Pennsylvania Real Estate Investment Trust
PEI
$124K ﹤0.01%
693
-374
-35% -$60.7K
NMM icon
7188
PUT
Navios Maritime Partners
NMM
$2.31B
$123K ﹤0.01%
+3,467
New +$109K
ZVO
7189
PUT
DELISTED
Zovio Inc. Common Stock
ZVO
$123K ﹤0.01%
14,800
+4,800
+48% +$44.4K
EGLE
7190
DELISTED
Eagle Bulk Shipping Inc.
EGLE
$123K ﹤0.01%
+3,923
New +$124K
GERN icon
7191
PUT
Geron
GERN
$821M
$122K ﹤0.01%
67,900
+29,200
+75% +$59K
NVGS icon
7192
PUT
Navigator Holdings
NVGS
$1.35B
$122K ﹤0.01%
+12,400
New +$129K
TOVX icon
7193
Theriva Biologics
TOVX
$10.2M
$122K ﹤0.01%
28
+21
+300% +$131K
QUOT
7194
PUT
DELISTED
Quotient Technology Inc
QUOT
$122K ﹤0.01%
+10,400
New +$144K
FTK icon
7195
CALL
Flotek Industries
FTK
$968M
$121K ﹤0.01%
4,317
-916
-18% -$26.1K
GPRK icon
7196
GeoPark
GPRK
$617M
$121K ﹤0.01%
+12,221
New +$109K
IGD
7197
Voya Global Equity Dividend and Premium Opportunity Fund
IGD
$516M
$121K ﹤0.01%
15,592
+424
+3% +$3.36K
UAN icon
7198
PUT
CVR Partners
UAN
$1.33B
$121K ﹤0.01%
3,700
+630
+21% +$20.9K
SCU
7199
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
$121K ﹤0.01%
+4,823
New +$151K
DSE
7200
DELISTED
Duff & Phelps Select MLP and Midstream Energy Fund Inc.
DSE
$121K ﹤0.01%
+2,075
New +$120K

Similar funds

Citadel Advisors's Q4 2017 Portfolio in Review

As of Q4 2017, Citadel Advisors held 8,908 positions worth $164B, up 26% from $130B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Citadel Advisors deployed $21.1B of net new capital in Q4 2017, opening 1,440 new positions and adding to 3,569 existing holdings. Its largest new stake was Celgene Corp: 3,708,916 shares worth $387M.

By sector, the portfolio is most concentrated in Technology at 6.1% of assets, down from 7% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Goldman Sachs, an estimated $441M trimmed.

  • Citadel Advisors's largest Q4 2017 buy was Celgene Corp: 3,708,916 shares worth $387M.
  • Citadel Advisors added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.16B increase.
  • Citadel Advisors's biggest Q4 2017 reduction was Goldman Sachs, cutting an estimated $441M.
  • Citadel Advisors fully exited CR Bard Inc. in Q4 2017, selling an estimated $209M.
  • Citadel Advisors's ten largest holdings make up 19% of its $164B portfolio in Q4 2017.
  • Citadel Advisors opened 1,440 new positions and closed 989 in Q4 2017.
  • Citadel Advisors's portfolio value rose 26% quarter-over-quarter to $164B.

Based on Citadel Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.